麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr.’s Vaccine Testimony

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Feb 17 2026

Full Issue

HRSA Seeks Feedback On 340B Drug Rebate Pilot Program Reboot

After the first attempt at a 340B rebate pilot stalled in court in December, the Health Resources and Services Administration is looking into a pilot that would require 340B program participants to pay full price for covered medications up front, then receive a rebate from manufacturers later. This time it is requesting feedback from providers, drugmakers, and others before moving forward.

The Health Resources and Services Administration is restarting its work on a controversial 340B Drug Pricing Program pilot program. In a Friday request for information, HRSA asked providers, drugmakers and other interested parties for feedback on whether it should implement a pilot program that would require hospitals, community health centers and other 340B program participants to pay full price for covered medications up front, then receive a rebate from manufacturers later. The solicitation represents HRSA鈥檚 second attempt to roll out a 340B rebate pilot, after the first stalled in court. (Early, 2/13)

More health industry developments 鈥

Nearly every major Medicare insurer got rid of enrollees 鈥 except Humana. (Herman, 2/16)

Humana completed its acquisition of the primary care clinic operator MaxHealth from private equity firm Arsenal Capital Partners. The deal adds 54 primary care clinics, four specialty sites and 24 affiliated facilities to Humana鈥檚 CenterWell healthcare services arm. The companies did not disclose financial details of the acquisition, and Humana declined to comment. (Tepper, 2/13)

Health systems are investing billions of dollars into inpatient facilities, driven by an aging population and increasing demand for specialized care. In recent years, providers have largely focused their investing on extensive outpatient projects. They also face ongoing cost pressures and regulatory uncertainty. Still, several are looking to add to their inpatient footprint. (Hudson, 2/13)

The rapid growth of ambulatory surgical centers by health systems and physician groups has captured the attention of medical device makers, which see an opportunity to grow their own businesses. Companies are developing products specifically for the facilities or adapting existing ones to fit within the spaces, budgets and training constraints. It鈥檚 not much of a gamble, as hospitals move procedures to the lower-cost settings and the Centers for Medicare and Medicaid Services approves reimbursement for procedures within the facilities. (Dubinsky, 2/13)

麻豆女优 Health News: Listen: Why Do I Need Prior Authorization?

Listen in as 鈥淟ife Kit鈥 host Marielle Segarra and health reporter Sarah Boden untangle the red tape that can make the prior authorization process frustrating. When the doctor says you need a prescription or treatment, sometimes you need approval from your health insurance first. That鈥檚 called prior authorization. Without that sign-off, insurance won鈥檛 pay. What triggers the need for prior authorization is not fully clear. It鈥檚 another 鈥渂lack box鈥 part of the health care system. (Boden, 2/17)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优